Cargando…

Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity

Lethal hit delivery by cytotoxic T lymphocytes (CTL) towards B lymphoma cells occurs as a binary, “yes/no” process. In non-hematologic solid tumors, however, CTL often fail to kill target cells during 1:1 conjugation. Here we describe a mechanism of “additive cytotoxicity” by which time-dependent in...

Descripción completa

Detalles Bibliográficos
Autores principales: Weigelin, Bettina, den Boer, Annemieke Th., Wagena, Esther, Broen, Kelly, Dolstra, Harry, de Boer, Rob J., Figdor, Carl G., Textor, Johannes, Friedl, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410835/
https://www.ncbi.nlm.nih.gov/pubmed/34471116
http://dx.doi.org/10.1038/s41467-021-25282-3
_version_ 1783747182847852544
author Weigelin, Bettina
den Boer, Annemieke Th.
Wagena, Esther
Broen, Kelly
Dolstra, Harry
de Boer, Rob J.
Figdor, Carl G.
Textor, Johannes
Friedl, Peter
author_facet Weigelin, Bettina
den Boer, Annemieke Th.
Wagena, Esther
Broen, Kelly
Dolstra, Harry
de Boer, Rob J.
Figdor, Carl G.
Textor, Johannes
Friedl, Peter
author_sort Weigelin, Bettina
collection PubMed
description Lethal hit delivery by cytotoxic T lymphocytes (CTL) towards B lymphoma cells occurs as a binary, “yes/no” process. In non-hematologic solid tumors, however, CTL often fail to kill target cells during 1:1 conjugation. Here we describe a mechanism of “additive cytotoxicity” by which time-dependent integration of sublethal damage events, delivered by multiple CTL transiting between individual tumor cells, mediates effective elimination. Reversible sublethal damage includes perforin-dependent membrane pore formation, nuclear envelope rupture and DNA damage. Statistical modeling reveals that 3 serial hits delivered with decay intervals below 50 min discriminate between tumor cell death or survival after recovery. In live melanoma lesions in vivo, sublethal multi-hit delivery is most effective in interstitial tissue where high CTL densities and swarming support frequent serial CTL-tumor cell encounters. This identifies CTL-mediated cytotoxicity by multi-hit delivery as an incremental and tunable process, whereby accelerating damage magnitude and frequency may improve immune efficacy.
format Online
Article
Text
id pubmed-8410835
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84108352021-09-22 Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity Weigelin, Bettina den Boer, Annemieke Th. Wagena, Esther Broen, Kelly Dolstra, Harry de Boer, Rob J. Figdor, Carl G. Textor, Johannes Friedl, Peter Nat Commun Article Lethal hit delivery by cytotoxic T lymphocytes (CTL) towards B lymphoma cells occurs as a binary, “yes/no” process. In non-hematologic solid tumors, however, CTL often fail to kill target cells during 1:1 conjugation. Here we describe a mechanism of “additive cytotoxicity” by which time-dependent integration of sublethal damage events, delivered by multiple CTL transiting between individual tumor cells, mediates effective elimination. Reversible sublethal damage includes perforin-dependent membrane pore formation, nuclear envelope rupture and DNA damage. Statistical modeling reveals that 3 serial hits delivered with decay intervals below 50 min discriminate between tumor cell death or survival after recovery. In live melanoma lesions in vivo, sublethal multi-hit delivery is most effective in interstitial tissue where high CTL densities and swarming support frequent serial CTL-tumor cell encounters. This identifies CTL-mediated cytotoxicity by multi-hit delivery as an incremental and tunable process, whereby accelerating damage magnitude and frequency may improve immune efficacy. Nature Publishing Group UK 2021-09-01 /pmc/articles/PMC8410835/ /pubmed/34471116 http://dx.doi.org/10.1038/s41467-021-25282-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Weigelin, Bettina
den Boer, Annemieke Th.
Wagena, Esther
Broen, Kelly
Dolstra, Harry
de Boer, Rob J.
Figdor, Carl G.
Textor, Johannes
Friedl, Peter
Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity
title Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity
title_full Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity
title_fullStr Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity
title_full_unstemmed Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity
title_short Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity
title_sort cytotoxic t cells are able to efficiently eliminate cancer cells by additive cytotoxicity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410835/
https://www.ncbi.nlm.nih.gov/pubmed/34471116
http://dx.doi.org/10.1038/s41467-021-25282-3
work_keys_str_mv AT weigelinbettina cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity
AT denboerannemieketh cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity
AT wagenaesther cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity
AT broenkelly cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity
AT dolstraharry cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity
AT deboerrobj cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity
AT figdorcarlg cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity
AT textorjohannes cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity
AT friedlpeter cytotoxictcellsareabletoefficientlyeliminatecancercellsbyadditivecytotoxicity